Medicine: Capsules, Apr. 21, 1958

¶ Trouble for iproniazid, the remarkable new anti-depression drug introduced last year (TIME, Dec. 16), was sparked last week by the death of a San Francisco woman whose physician prescribed it. A coroner's jury ruled that her death (of hepatitis) was directly due to the drug, which is trade-named Marsilid by its maker, Hoffman-La Roche Inc. of Nutley. N.J. In January and February the drug house cut the recommended daily dosage for moderately depressed patients from 150 milligrams to a maximum of 50. It tried to notify most practicing U.S. physicians, but the information never reached the woman's doctor. Last week...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!